| Website | lspvc.com |
| Phone | +1 (617) 452 1000 |
| Employees |
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing to private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. For example, LSP was a founding investor in Crucell, DNage, Qiagen, Rhein Biotech and Pharming.
With over EUR 500 million under management and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
| Company | Date | Round | Size | Participants |
| Prosensa | 1/12 | Unattributed | €23M | 7 |
| Probiodrug | 1/12 | Unattributed | €15M | 6 |
| Atlas Genetics | 7/11 | Series B | £16.9M | 5 |
| Mendor | 6/11 | Series B | €8.1M | 4 |
| Sapiens | 6/11 | Series A | €13M | 3 |
| Cobalt Technologies | 5/11 | Series D | $20M | 5 |
| Nexstim | 1/11 | Unattributed | €11M | 6 |
| Seahorse Bioscience | 3/10 | Series D | $5M | 7 |
| arGEN-X | 2/10 | Series A | $4.5M | 7 |
| Promethera Biosciences | 2/10 | Series A | $7.3M | 3 |
| Kreatech Diagnostics | 1/10 | Series B | $2.7M | 2 |
| Merus | 1/10 | Series B | €21.7M | 4 |
| Cellerix | 1/10 | Series C | $37.7M | 6 |
| Harvest Automation | 1/10 | Series A | $4M | 2 |
| Curetis | 12/09 | Series A | €18.5M | 4 |
| Kreatech Diagnostics | 11/09 | Unattributed | $3M | 2 |
| Trinity Biosystems | 11/09 | Unattributed | $7.5M | 5 |
| Probiodrug | 11/09 | Series B | $54M | 8 |
| Pasteuria Bioscience | 7/09 | Series B | $2.8M | 3 |
| Pronota | 6/09 | Series B | $7.36M | 7 |
| BMEYE | 1/09 | Series A | 3 | |
| Cobalt Technologies | 10/08 | Series C | $25M | 6 |
| Syntaxin | 10/07 | Series B | $32M | 5 |
| Hyperion Therapeutics | 10/07 | Debt | $15M | 2 |
| Cellerix | 9/07 | Series B | €27.2M | 6 |
| FlowCardia | 8/07 | Series C | $30M | 9 |
| Isto Technologies | 8/07 | Series E | $8.8M | 4 |
| Movetis | 1/07 | Series A | €49M | 7 |
| Pronota | 8/06 | Series A | $10.6M | 4 |
| Pronota | 4/06 | Series A | $7.8M | 2 |
| DNage | 4/05 | Series A | $1.94M | 2 |